that the accumulators are only halfway to their targeted goal. They doing pretty good in the 9.5 to 10 range, but time is running short. After they're done accumulating, then we'll get a run to the level that Russell funds will prenegotiate. This is fun, especially with phase 3 results just around the corner!
I wonder if the shorts currently in place are going to cover in the heat of the scramble for shares?Or are they going to double down and hope for a pullback before anymore catalysts kick in to rocket the stock up even higher?
The way this is going, the number of shares likely to be required by the tracker funds in June cannot fail to drive the share price to a level based upon peak revenue projections (discounted for the cash now vs cash later factor).
Who can afford to, or have any motivation to, sell millions of shares to the funds at a price far below what they are likely to be worth with FDA / EMEA approval?